Investors
A bioeconomy platform built for the next decade.
Confidential materials — pitch deck, financial model, technical dossier, and operational updates — are available in our investor portal.
$120B+ market
Global bioactives demand outpacing supply across cosmetics, nutraceuticals, and pharma inputs.
Defensible IP
Endemic East African flora + plant cell culture know-how create a durable moat.
Pipeline visibility
Five product verticals, three commercial today, two in scaled R&D.
Investor Portal
Access confidential materials.
Sign in with your investor account, or request access if you're a prospective investor.